NAMD Urges CMS to Mitigate State Costs on Controversial Alzheimer’s Drug
In formal comments, NAMD calls on Medicare to step up and cover the Alzheimer’s drug Aduhelm. Failure to...
Medicaid Members
Dual Eligibles
Many individuals are dually eligible for Medicare and Medicaid. This creates both challenges and opportunities for managing both programs and improving health outcomes.
Resources
NAMD Urges Medicare to Not to Shift Cost of Alzheimer’s Drug to Medicaid
On August 11, 2021, NAMD sent a letter to CMS asking that Medicare not shift the cost of...
Medicare Must Not Cost Shift Alzheimer’s Care to Medicaid
NAMD explains the serious cost implications of Medicare’s coverage decision on the Alzheimer’s drug Aduhelm for state Medicaid...
NAMD Submits Feedback to Congress on Proposed Home- and Community-Based Services Access Act
On April 30, NAMD sent a letter to Senators Hassan, Brown, and Casey and Representative Dingell with feedback...
NAMD Recommends Extended Implementation Timeline for Proposed Interoperability Rule
On June 3, 2019, NAMD submitted comments to the Centers for Medicare and Medicaid Services (CMS) on a...
NAMD Provides Comments on Proposed Permanent Authorization of Duals Plans
In April 2018, NAMD provided comments supporting an ambitious federal standard for Medicaid integration of Duals Special Needs...
NAMD and Sister State Associations Urge Reauthorization of Money Follows the Person
In March 2018, NAMD joined our sister state associations in calling on Congress to reauthorize the Money Follows...
NAMD Calls for the Hill to Reauthorize Expiring Programs
In March 2017, NAMD sent a letter to Congressional leaders calling for the timely reauthorization of the Children’s...